Safety and Efficacy of SH T00660AA in Treatment of Endometriosis
NCT00225186 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 168
Last updated 2014-01-09
Summary
The purpose of this study is to demonstrate safety and efficacy of SH T00660AA for the treatment of endometriosis
Conditions
- Endometriosis
Interventions
- DRUG
-
Visanne (SH T00660AA , BAY86-5258)
Daily long-term drug treatment (12 months), and post-treatment observation (6 months) in a subgroup of patients
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2008-03-31
- Completion
- 2008-03-31
Countries
- Germany
- Italy
- Ukraine
Study Locations
More Related Trials
-
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
NCT03573336 ·Status: TERMINATED ·Phase: PHASE2
-
Visanne Post-approval Observational Study (VIPOS)
NCT01266421 ·Status: COMPLETED
-
A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis
NCT04808843 ·Status: COMPLETED
-
A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants
NCT04495855 ·Status: COMPLETED
-
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
NCT04851483 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670
NCT01816815 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women
NCT02434640 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
NCT03481842 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain
NCT00185341 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best
NCT03373422 ·Status: TERMINATED ·Phase: PHASE2
-
Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants
NCT05517746 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
NCT07164183 ·Status: RECRUITING ·Phase: PHASE3
-
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
NCT00244452 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
NCT00784693 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
NCT00318500 ·Status: COMPLETED ·Phase: PHASE2
-
Endometriosis Trial: Study of NBI-56418 in Endometriosis
NCT00109512 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Expression Analysis of the Endometrium After Endometrial Biopsy in Fertile Women
NCT02219425 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
NCT07260669 ·Status: RECRUITING ·Phase: PHASE2
-
Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas.
NCT02047838 ·Status: COMPLETED
-
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
NCT01190475 ·Status: COMPLETED ·Phase: PHASE2
-
Goserline Acetate VS Dienogest in Endometriosi
NCT05013242 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas
NCT02599077 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Continuous Versus Cyclic Oral Contraceptives for Endometriosis
NCT02237131 ·Status: UNKNOWN ·Phase: PHASE4
-
Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF
NCT03142035 ·Status: UNKNOWN ·Phase: NA
-
Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 2 With and Without Suppression by Dienogest
NCT02575248 ·Status: UNKNOWN ·Phase: PHASE4